magnifying glass icon

New data uncovers Aussies’ most painful moments as access to treatment expands

Originally published: Retail Pharmacy, 2 June 2025

The true-blue experience of acute pain has been revealed following the release of the ‘Australian Acute Pain Survey’ – Australia’s largest study on acute pain – which highlights playing sport (46.5%), running (25.5%), or in the bedroom (17.9%) are some of the most common settings where Aussies get injured.[1]

The findings follow the Therapeutic Goods Administration (TGA)’s approval of CELEBREX RELIEF (celecoxib 200 mg) as a Schedule 3 pharmacist-only medicine, making it the first and currently only treatment of its kind (a COX-2 selective non-steroidal anti-inflammatory medication) available without a prescription in Australia for short-term relief from acute pain caused by muscle and joint injuries or period pain in adults.[2]

Australians suffering from muscle and joint injuries or period pain can now access short-term acute pain relief by asking their pharmacist for CELEBREX RELIEF, bypassing GP wait times and costs.

Viatris and PureProfile. 2025. Australian Acute Pain Survey. Data on File.

Read the full article >

Continue Exploring

More data, insights and media from the experts

SIGN UP NOW

Stay up to date with our latest news, insights and trends reports

SIGN UP NOW

Stay up to date with our latest news, insights and trends reports

Pureprofile logo
This website uses cookies

We use cookies on our site to help give you a better experience. By continuing you consent to us using this data. You can find out more in our Privacy Policy.